TANDEM DIABETES CARE INC (TNDM)

↓ Download CSV

CIK 0001438133 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, TANDEM DIABETES CARE INC reported revenue of $1.01B, up 7.9% from the prior year. The company ran a net loss, with a net margin of -20.2% and a gross margin of 53.8%. It held $881.11M in total assets against $725.94M in total liabilities.

Key ratios (FY2025)

53.8%
Gross margin
-18.5%
Operating margin
-20.2%
Net margin
-131.9%
Return on equity
+7.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.01B$940.20M$747.72M$801.22M$702.80M$498.83M$362.31M$183.87M$107.60M$84.25M
Cost of Revenue$468.72M$450.63M$380.03M$388.23M$326.58M$238.31M$168.09M$94.04M$63.51M$60.66M
Gross Profit$546.01M$489.57M$367.69M$412.99M$376.21M$260.52M$194.21M$89.82M$44.09M$23.59M
Operating Income-$187.26M-$99.13M-$233.23M-$92.85M$22.65M-$7.96M-$16.72M-$44.63M-$62.94M-$78.05M
Net Income-$204.71M-$96.03M-$222.61M-$94.59M$15.57M-$34.38M-$24.75M-$122.61M-$73.03M-$83.45M
EPS (Diluted)$-3.04$-1.47$-3.43$-1.47$0.24$-0.56$-0.42
Total Assets$881.11M$967.66M$952.66M$1.05B$905.14M$716.41M$326.11M$206.29M$95.35M$112.39M
Total Liabilities$725.94M$704.56M$639.03M$612.84M$472.02M$350.11M$131.13M$75.02M$124.49M$118.32M
Shareholders' Equity$155.17M$263.10M$313.63M$439.95M$433.11M$366.31M$194.98M$131.28M-$29.15M-$5.93M
Cash & Equivalents$90.63M$69.23M$58.87M$172.52M$71.18M$94.61M$51.17M$41.83M$13.70M$44.68M
Operating Cash Flow-$9.72M$24.23M-$31.81M$50.46M$111.36M$24.67M$41.91M-$8.32M-$66.14M-$61.17M
Capital Expenditures$19.95M$19.23M$26.80M$34.10M$14.18M$27.41M$19.54M$2.99M$5.72M$8.93M
Shares Outstanding68.29M66.26M65.55M64.51M63.83M62.34M59.40M57.55M10.12M3.11M